Lupin's Divalproex Sodium ANDA078790 Receives AP Status from FDA
Lupin's Abbreviated New Drug Application (ANDA078790) for Divalproex Sodium has received Approval Pending (AP) status from the FDA. This application is for a generic formulation of Depakote, indicated for epilepsy and bipolar disorder.